News

Irish Medical Times6h
Two new indications of Tremfya (guselkumab) approved for the treatment of Inflammatory Bowel Disease
Tremfya is the first and only fully-human, dual-acting IL-23p19 subunit inhibitor approved in both ulcerative colitis and ...